YZ129 is an inhibitor of the HSP90-phosphatase-NFAT pathway with anti-glioblastoma activity; it directly binds to heat shock protein 90 (HSP90), inhibits NFAT nuclear translocation (IC50 = 820 nM), induces G2/M phase cell cycle arrest in glioblastoma (GBM) cells, promotes apoptosis, and suppresses tumor cell proliferation and migration.